Literature DB >> 7774049

Presence of mRNA for interferon-gamma (IFN-gamma) in blood mononuclear cells is associated with an active stage I sarcoidosis.

C Swider1, A Laba, A Moniewska, J Gerdes, H D Flad, A Lange.   

Abstract

Peripheral blood mononuclear cells (PBMC) and bronchoalveolar lavage (BAL) cells obtained from sarcoidosis patients were investigated for the presence of mRNA for IFN-gamma. RNA was extracted from freshly obtained cells. In 12 cases PBMC were studied and in seven cases BAL cells were also available for concomitant investigation. In eight patients mRNA for IFN-gamma was present in blood and was significantly associated with stage I disease (P = 0.030). By comparison, BAL cells were less frequently positive for IFN-gamma transcripts (P = 0.039). Only one patient had simultaneous expression of IFN-gamma gene in blood and BAL cells. All other patients including four positive in blood were negative in BAL. The presence of IFN-gamma transcripts in PBMC was significantly associated with the capacity of these cells to generate IFN-gamma in unstimulated cultures. PBMC from patients showing IFN-gamma mRNA in blood were frequently high IFN-gamma producers in anti-CD3 MoAb-stimulated cultures.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774049      PMCID: PMC1534459          DOI: 10.1111/j.1365-2249.1995.tb03713.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.

Authors:  C Prior; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

2.  Modulation of accessory molecules on lung T cells.

Authors:  E Yamaguchi; N Okazaki; A Itoh; S Abe; Y Kawakami
Journal:  Chest       Date:  1990-06       Impact factor: 9.410

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Characterization of T lymphocyte and monocyte populations in HLA B8/DRw3 normal individuals and in patients with dermatitis herpetiformis.

Authors:  R P Hall; W M Leiserson; T M Chused; T J Lawley
Journal:  J Invest Dermatol       Date:  1984-03       Impact factor: 8.551

5.  Production of cytokines in sarcoid lymph nodes: preferential expression of interleukin-1 beta and interferon-gamma genes.

Authors:  O Devergne; D Emilie; M Peuchmaur; M C Crevon; M F D'Agay; P Galanaud
Journal:  Hum Pathol       Date:  1992-03       Impact factor: 3.466

6.  Detection of endogenous cytokines in sera or in lymph nodes obtained from patients with sarcoidosis.

Authors:  M Asano; T Minagawa; M Ohmichi; Y Hiraga
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

7.  Recurrence of sarcoidosis in pulmonary allograft recipients.

Authors:  B A Johnson; S R Duncan; N P Ohori; I L Paradis; S A Yousem; W F Grgurich; J H Dauber; B P Griffith
Journal:  Am Rev Respir Dis       Date:  1993-11

8.  Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones.

Authors:  E Maggi; P Parronchi; R Manetti; C Simonelli; M P Piccinni; F S Rugiu; M De Carli; M Ricci; S Romagnani
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

9.  Phenotype of blood monocytes and alveolar macrophages in interstitial lung disease.

Authors:  H C Hoogsteden; J J van Dongen; P T van Hal; M Delahaye; W Hop; C Hilvering
Journal:  Chest       Date:  1989-03       Impact factor: 9.410

10.  Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.

Authors:  B W Robinson; T L McLemore; R G Crystal
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

View more
  1 in total

1.  T-bet and interleukin-27: possible TH1 immunomodulators of sarcoidosis.

Authors:  Wei Sheng Joshua Loke; Araluen Freeman; Linda Garthwaite; Silvie Prazakova; Mijeong Park; Kenneth Hsu; Paul S Thomas; Cristan Herbert
Journal:  Inflammopharmacology       Date:  2015-08-09       Impact factor: 4.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.